XRCC3 and chronic myelogenous leukemia, BCR-ABL1 positive: No association was observed between the prognostic factors (age, gender, blast and WBC count, ACA, and Sokal and Hasford risk groups) and the XRCC3 Thr241Met variant genotypes in patients with CML.